Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Other financing activities: 2022-2024

Historic Other financing activities for Lexeo Therapeutics (LXEO) over the last 3 years, with Dec 2024 value amounting to $12.5 million.

  • Lexeo Therapeutics' Other financing activities rose 70.53% to $3.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was $5.3 million, marking a year-over-year change of. This contributed to the annual value of $12.5 million for FY2024, which is 309.92% up from last year.
  • As of FY2024, Lexeo Therapeutics' Other financing activities stood at $12.5 million, which was up 309.92% from $3.0 million recorded in FY2023.
  • Over the past 5 years, Lexeo Therapeutics' Other financing activities peaked at $12.5 million during FY2024, and registered a low of $1.8 million during FY2022.
  • Its 3-year average for Other financing activities is $5.8 million, with a median of $3.0 million in 2023.
  • Data for Lexeo Therapeutics' Other financing activities shows a peak YoY spiked of 309.92% (in 2024) over the last 5 years.
  • Over the past 3 years, Lexeo Therapeutics' Other financing activities (Yearly) stood at $1.8 million in 2022, then surged by 70.86% to $3.0 million in 2023, then skyrocketed by 309.92% to $12.5 million in 2024.